Jacot, W.; Lopez-Crapez, E.; Mollevi, C.; Boissière-Michot, F.; Simony-Lafontaine, J.; Ho-Pun-Cheung, A.; Chartron, E.; Theillet, C.; Lemoine, A.; Saffroy, R.;
et al. BRCA1 Promoter Hypermethylation is Associated with Good Prognosis and Chemosensitivity in Triple-Negative Breast Cancer. Cancers 2020, 12, 828.
https://doi.org/10.3390/cancers12040828
AMA Style
Jacot W, Lopez-Crapez E, Mollevi C, Boissière-Michot F, Simony-Lafontaine J, Ho-Pun-Cheung A, Chartron E, Theillet C, Lemoine A, Saffroy R,
et al. BRCA1 Promoter Hypermethylation is Associated with Good Prognosis and Chemosensitivity in Triple-Negative Breast Cancer. Cancers. 2020; 12(4):828.
https://doi.org/10.3390/cancers12040828
Chicago/Turabian Style
Jacot, William, Evelyne Lopez-Crapez, Caroline Mollevi, Florence Boissière-Michot, Joelle Simony-Lafontaine, Alexandre Ho-Pun-Cheung, Elodie Chartron, Charles Theillet, Antoinette Lemoine, Raphael Saffroy,
and et al. 2020. "BRCA1 Promoter Hypermethylation is Associated with Good Prognosis and Chemosensitivity in Triple-Negative Breast Cancer" Cancers 12, no. 4: 828.
https://doi.org/10.3390/cancers12040828
APA Style
Jacot, W., Lopez-Crapez, E., Mollevi, C., Boissière-Michot, F., Simony-Lafontaine, J., Ho-Pun-Cheung, A., Chartron, E., Theillet, C., Lemoine, A., Saffroy, R., Lamy, P.-J., & Guiu, S.
(2020). BRCA1 Promoter Hypermethylation is Associated with Good Prognosis and Chemosensitivity in Triple-Negative Breast Cancer. Cancers, 12(4), 828.
https://doi.org/10.3390/cancers12040828